| COLLABORATION-PARTNER |
COLLABORATION-PARTNER |
90%
|
From 2022 to 2024, we generated revenue from an upfront payment and development funding related to an asset purchase agreement with a collaboration partner. |
| SNYNF |
Sanofi |
72%
|
rotagonist Therapeutics, Inc., Sanofi SA, Takeda Pharmaceuticals, Teva Pharmaceuticals, Topas Therapeutics GmbH, and Zedira GmbH. Sales and Marketing Given our stage of development, we have not yet e… |
| SNYNF |
Sanofi |
72%
|
Reciprocal relationship from SNYNF graph: Reciprocal relationship from EQ graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from EQ graph: rotagonist Therapeutics, Inc., Sanofi… |
| ATTENUATE-BIOPHARMACEUTICALS-INC |
ATTENUATE-BIOPHARMACEUTICALS-INC |
62%
|
expired at the end of 2025, which, among other provisions in the law, are anticipated to reduce the number of Americans with health insurance. The OBBBA also is expected to reduce Medicaid spending a… |
| BINANCE-HOLDINGS-LTD |
BINANCE-HOLDINGS-LTD |
62%
|
owingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government. In addition, a claim including items or services resulting from a viola… |
| BIONIZ-THERAPEUTICS-INC |
BIONIZ-THERAPEUTICS-INC |
62%
|
expired at the end of 2025, which, among other provisions in the law, are anticipated to reduce the number of Americans with health insurance. The OBBBA also is expected to reduce Medicaid spending a… |
| DEVELOPMENT-TAX-INCENTIVE-EQUILLIUM-AUSTRALIA-PT |
DEVELOPMENT-TAX-INCENTIVE-EQUILLIUM-AUSTRALIA-PT |
62%
|
mated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. Lease expense for lease payments is recognized on a straight-li… |
| DYNAMEX-OPERATIONS-WEST-INC |
DYNAMEX-OPERATIONS-WEST-INC |
62%
|
1, the American Rescue Plan Act of 2021 was signed into law, which eliminated the statutory Medicaid drug rebate cap, previously set at 100% of a drug’s average manufacturer price, for single source … |
| EQUILLIUM-AUSTRALIA-PTY-LTD |
EQUILLIUM-AUSTRALIA-PTY-LTD |
62%
|
rties on which we rely fail, or are perceived to have failed, to address or comply with applicable data privacy and security obligations, we could face significant consequences, including but not lim… |
| LIFESCI-CAPITAL-LLC |
LIFESCI-CAPITAL-LLC |
62%
|
owingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government. In addition, a claim including items or services resulting from a viola… |
| PRIME-TRUST-LLC |
PRIME-TRUST-LLC |
62%
|
owingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government. In addition, a claim including items or services resulting from a viola… |
| SECURITIES-INVESTOR-PROTECTION-CORPORATION |
SECURITIES-INVESTOR-PROTECTION-CORPORATION |
62%
|
owingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government. In addition, a claim including items or services resulting from a viola… |
| VOYAGER-DIGITAL-HOLDINGS |
VOYAGER-DIGITAL-HOLDINGS |
62%
|
owingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government. In addition, a claim including items or services resulting from a viola… |
| VYGR |
Voyager Therapeutics, Inc. |
62%
|
Reciprocal relationship from VYGR graph: Reciprocal relationship from EQ graph: owingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal gov… |
